BDX

Becton, Dickinson and Company
HealthcareMedical Instruments & SuppliesNASDAQ
$158.43
+$0.35 (0.22%)today
Conviction
0/ 10
Fair Value$196.08
Upside+23.77%
Signal0
Market Cap$56.0B
52W Range$127.59–$187.35
Next EarningsMay 7

Price History

Quick Take

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

Trailing P/E25.2x
Forward P/E11.4x
P/S2.6x
EPS (TTM)$6.12
Analyst Target$196.08
Analyst Upside23.8%

No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10qMar 2
Conviction: unchanged
BDX Q1 FY26: Tariff Headwinds & Segment Divergence

Q1 FY26 shows mixed execution: solid segment growth in Connected Care and Interventional offset by tariff pressure and China softness. Waters spin complete. Litigation risks quantified but not show-st...